You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 217 No. 12, September 20, 1971 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Alkylating Agents and

Daniel G. Miller, MD

JAMA. 1971;217(12):1662-1665.


Abstract

Eleven patients with malignant lymphoma had sperm counts done in the course of maintenance treatment with the alkylating agents chlorambucil or cyclophosphamide. Of the nine patients treated with chlorambucil, all had aspermia after treatment with doses ranging from 10.1 to 17.7 mg/kg of body weight. The two patients treated with cyclophosphamide had aspermia after a total dose of 227 and 980 mg/kg. One patient has been observed for one year following the cessation of alkylating agents and no return of spermatogenesis has occurred. Three patients had had radiation therapy to portals below the diaphragm and in these cases scatter irradiation might have been a contributing factor.



Author Affiliations

From the Preventive Medicine Institute— Strang Clinic, and the Memorial Hospital for Cancer and Allied Diseases, New York.


Footnotes

Reprint requests to 55 E 34th St, New York 10016 (Dr. Miller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Endocrine Effects of Nonhormonal Antineoplastic Therapy
Yeung et al.
Endocr. Rev. 1998;19:144-172.
ABSTRACT | FULL TEXT  

Review : Infertility after chemotherapy: A review of the risks and strategies for prevention
Lenz and Valley
J Oncol Pharm Pract 1996;2:75-100.
ABSTRACT  

Gonadal Dysfunction in Patients Receiving Chemotherapy for Cancer
SCHILSKY et al.
ANN INTERN MED 1980;93:109-114.
ABSTRACT  

Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications
SCHEIN and WINOKUR
ANN INTERN MED 1975;82:84-95.
ABSTRACT  

Immunosuppressive and Cytotoxic Drugs in Dermatology
Dantzig
Arch Dermatol 1974;110:393-406.
ABSTRACT  

Effect of Drug Treatment for Lymphoma on Male Reproductive Capacity: Studies of Men in Remission After Therapy
SHERINS and DeVITA
ANN INTERN MED 1973;79:216-220.
ABSTRACT  

Reversible Drug-Induced Sterility in a Patient With Acute Leukemia
Hinkes and Plotkin
JAMA 1973;223:1490-1491.
ABSTRACT  

Cytotoxic Drugs in Treatment of Nonmalignant Diseases
STEINBERG et al.
ANN INTERN MED 1972;76:619-642.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.